suPAR Is Associated with Progressive Albuminuria in Type 1 Diabetes
Clinical Journal of the American Society of Nephrology · 06.11.2026
DOI: 10.2215/cjn.0000001246 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, online erschienen am 06.11.2026. Verfasst von Anis Ismail und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background and Objectives Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived glycoprotein implicated in chronic kidney disease (CKD) and glomerulopathy. suPAR predicts CKD progression, but whether it is associated with longitudinal albuminuria worsening, including in patients without established albuminuria, is untested in diabetic kidney disease (DKD). We examined this in type 1 diabetes using albumin excretion rate (AER) trajectory. Design, Setting, Participants, & Measurements Post hoc analysis of 506 participants with a single baseline suPAR measurement from the PERL trial, a 3-year multicenter randomized controlled trial in type 1 diabetes with early-to-moderate DKD. Linear mixed models estimated suPAR’s association with AER and iohexol-measured glomerular filtration rate (iGFR) trajectories. Structural equation modeling assessed whether albuminuria level accounted for the association between suPAR and iGFR decline. Results Mean age was 51 years, 34% female, diabetes duration 35 years, iGFR 68 mL/min/1.73 m 2 , median AER 44 μg/min, and median suPAR 3.43 ng/mL. Each suPAR doubling was associated with 11.6% per year additional AER increase (P
Autor:innen und Institutionen
- Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX.
- Department of Biobehavioral Nursing and Health Informatics, School of Nursing, University of Washington, Seattle, WA.
- John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX.
- Department of Epidemiology, Rush University, Chicago, IL.
- Department of Health Science & Clinical Practice, Thomas Jefferson University, Philadelphia, PA.
- Department of Medicine, Harvard Medical School, Boston, MA.
ORCID-Profile: Anis Ismail, Alexi Vasbinder, Bobby Bobby, Ramya Elangovan, Christina Hutten, Pennelope Kunkle, Alessandro Doria, Rodica Pop-Busui
Zitieren
APA
Ismail, A., Vasbinder, A., Farhat, T., Bobby, B., Elangovan, R., Hutten, C., Shaikh, I., Kunkle, P., Doria, A., Pop-Busui, R., Hayek, S. S., & PERL Study Group (2026). suPAR Is Associated with Progressive Albuminuria in Type 1 Diabetes. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000001246
Vancouver
Ismail A, Vasbinder A, Farhat T, Bobby B, Elangovan R, Hutten C, et al. suPAR Is Associated with Progressive Albuminuria in Type 1 Diabetes. Clinical Journal of the American Society of Nephrology. 2026. doi:10.2215/cjn.0000001246
BibTeX
@article{Ismail2026,
author = {Ismail, Anis and Vasbinder, Alexi and Farhat, Theresa and Bobby, Bobby and Elangovan, Ramya and Hutten, Christina and Shaikh, Iman and Kunkle, Pennelope and Doria, Alessandro and Pop-Busui, Rodica and Hayek, Salim S and PERL Study Group, PERL Study Group},
title = {suPAR Is Associated with Progressive Albuminuria in Type 1 Diabetes},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
doi = {10.2215/cjn.0000001246}
}
EUVIMED